Contact
QR code for the current URL

Story Box-ID: 984887

Apogenix AG Im Neuenheimer Feld 584 69120 Heidelberg, Germany http://www.apogenix.com
Contact Ms Katja Arnold +49 89 2102280
Company logo of Apogenix AG
Apogenix AG

Apogenix präsentiert neue Daten zu Asunercept auf dem ESMO Immuno-Oncology Congress

(PresseBox) (Heidelberg, )
Das auf Immunonkologie spezialisierte biopharmazeutische Unternehmen Apogenix AG gab heute bekannt, dass neue Daten zur Leitsubstanz Asunercept in einem Poster auf dem ESMO Immuno-Oncology Congress 2019 präsentiert werden. Der Kongress findet vom 11.-14. Dezember 2019 im Palexpo in Genf, Schweiz, statt. Die Daten sind das Ergebnis einer Forschungskooperation mit Benoit Van den Eynde und seinem Team am Ludwig Institute for Cancer Research in Brüssel, Belgien.

Titel des Posters: „The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: rationale and results from an enhanced TiRP model“ (Poster #118P)
Präsentation des Posters: 12. Dezember, 12:15 Uhr
Referent: Dr. Andriy Krendyukov, VP Cqphbah Qwapmdt, Tjqfsxcw LL
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.